Lau Tat San, Li Yonggang, Kameoka Masanori, Ng Tzi Bun, Wan David Chi Cheong
Department of Biochemistry, The Chinese University of Hong Kong, Shatin, NT, Hong Kong, China.
FEBS Lett. 2007 Jul 10;581(17):3253-9. doi: 10.1016/j.febslet.2007.06.011. Epub 2007 Jun 15.
RNA interference (RNAi) has become one of the most powerful and popular approach on gene silencing in clinical research study especially in virology due to the gene-specific suppression property of small interfering RNA (siRNA). In this report, we demonstrate that expression of vector-mediated small hairpin RNA (shRNA) against human immunodeficiency virus type 1 (HIV-1) integrase (IN), one of the three important enzymes in HIV infection by controlling the integration of viral RNA to host DNA, could suppress the protein synthesis of EGFP-tagged IN in HeLa cell model efficiently. Furthermore, we show that IN shRNA can successfully reduce the HIV particles production in 293T cells at the level similar to the positive control of HIV-1 tat shRNA. These results provide the therapeutic possibility of HIV replication using RNAi against HIV-1 integrase.
由于小干扰RNA(siRNA)具有基因特异性抑制特性,RNA干扰(RNAi)已成为临床研究尤其是病毒学领域中最强大且最常用的基因沉默方法之一。在本报告中,我们证明了载体介导的针对人类免疫缺陷病毒1型(HIV-1)整合酶(IN)的小发夹RNA(shRNA)的表达,通过控制病毒RNA与宿主DNA的整合,可有效抑制HeLa细胞模型中EGFP标记的IN的蛋白质合成。此外,我们表明IN shRNA能够成功降低293T细胞中HIV颗粒的产生,其水平与HIV-1 tat shRNA阳性对照相似。这些结果为利用针对HIV-1整合酶的RNAi治疗HIV复制提供了可能性。